Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study
European Journal of Clinical Pharmacology · 2025
DOI: 10.1007/s00228-024-03792-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Wei Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Cyclosporine, Hematopoietic Stem Cell Transplantation, Acute Kidney Injury, Immunosuppressive Agents. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
BACKGROUND: The potential nephrotoxicity of cyclosporine A (CsA) has been a problem for treating graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the relationship between CsA blood concentration and acute kidney injury (AKI) in pediatric patients after allo-HSCT remains unclear. METHODS: We performed a retrospective study including pediatric patients who received allo-HSCT in West China Second Hospital of Sichuan University from 2000 to 2022 and collected their clinical data. Included patients' CsA blood concentration were divided into three cohorts according to the guideline. Multivariate logistic regression was used to estimate the relationship between AKI and CsA blood concentration and other factors. And the maximum cut-off value for the safe blood concentration range of CsA was obtained by the receiver operating characteristic (ROC) curve. RESULTS: Seventy-nine patients (average age 6.75 ± 4.25) were included. The incidence of kidney injury for three CsA blood concentration cohorts ( 300 ng/ml) were 21.30%, 23.50%, and 66.70%, respectively. A multivariate logistic regression identified CsA blood concentration (> 300 ng/ml) and infection were risk factors for AKI (OR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, Chengdu, 610041, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, 610041, China.
- National Drug Clinical Trial Institute, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
- Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
- West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
Förderung
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Shi, W., Qiu, X., Huang, L., Zeng, L., Lu, R., Li, H., Zou, K., Jia, Z., Cheng, G., Yu, Q., Zhao, L., & Zhang, L. (2025). Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03792-5
Vancouver
Shi W, Qiu X, Huang L, Zeng L, Lu R, Li H, et al. Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03792-5
BibTeX
@article{Shi2025,
author = {Shi, Wei and Qiu, Xin and Huang, Liang and Zeng, Linan and Lu, Runxin and Li, Hailong and Zou, Kun and Jia, Zhijun and Cheng, Guo and Yu, Qin and Zhao, Limei and Zhang, Lingli},
title = {Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study},
journal = {European Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1007/s00228-024-03792-5}
}
EUVIMED